Systemic Exposure to Fluticasone Propionate Administered via Metered-Dose Inhaler Containing Chlorofluorocarbon or Hydrofluoroalkane Propellant

被引：0
|
作者：
Alison E. Mackie
Jo E. McDowall
Pietro Ventresca
Alan Bye
Christine Falcoz
Peter T. Daley-Yates
机构：
[1] Lilly Research Centre,Clinical Pharmacology
[2] Glaxo Wellcome Research and Development,undefined
[3] Glaxo Wellcome Research and Development,undefined
来源：
Clinical Pharmacokinetics | 2000年 / 39卷
关键词：
Fluticasone Propionate; Absolute Bioavailability; Chlorofluorocarbon; Urinary Cortisol; Urinary Cortisol Excretion;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：17 / 22
页数：5
相关论文
共 42 条
  • [31] Cumulative dose-response study of non-CFC propellant HFA 134a salbutamol sulfate metered-dose inhaler in patients with asthma
    Kleerup, EC
    Tashkin, DP
    Cline, AC
    Ekholm, CP
    CHEST, 1996, 109 (03) : 702 - 707
  • [32] Systemic exposure and urinary cortisol effects of fluticasone propionate formulated with hydrofluoroalkane in 4-to 11-year-olds with asthma
    Kim, Kenneth T.
    Milgrom, Henry
    Yoon, Y. Kellie
    Levy, Arden L.
    Matz, Paul
    Welch, Michael J.
    Cahn, Anthony
    Collins, David A.
    Kathman, Steven
    Mehta, Rashmi
    Su, Sheng-Fang
    Kunka, Robert L.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (01) : 108 - 116
  • [33] Respirable dose delivery of fluticasone propionate from a small valved holding chamber, a compact breath actuated integrated vortex device and a metered dose inhaler
    Nair, Arun
    Menzies, Daniel
    Barnes, Martyn
    Burns, Patricia
    McFarlane, Lesley
    Lipworth, Brian J.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 66 (01) : 20 - 26
  • [34] Pharmacokinetics of fluticasone propionate and salmeterol delivered as a combination dry powder via a capsule-based inhaler and a multi-dose inhaler
    Mehta, Rashmi
    Daley-Yates, Peter T.
    Jenkins, Kevin
    Bianco, Joseph
    Stylianou, Anastasia
    Louey, Margaret D.
    Chan, Robert H.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2014, 29 (01) : 66 - 73
  • [35] Assessment of lung deposition and analysis of the effect of fluticasone/salmeterol hydrofluoroalkane (HFA) pressurized metered dose inhaler (pMDI) in stable persistent asthma patients using functional respiratory imaging
    De Backer, J.
    Van Holsbeke, C.
    Vos, W.
    Vinchurkar, S.
    Dorinsky, P.
    Rebello, J.
    Mangale, M.
    Hajian, B.
    De Backer, W.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2016, 10 (08) : 927 - 933
  • [36] Long-term efficacy and safety of fluticasone propionate powder administered once or twice daily via inhaler to patients with moderate asthma
    ZuWallack, R
    Adelglass, J
    Clifford, DP
    Duke, SP
    Wire, PD
    Faris, M
    Harding, SM
    CHEST, 2000, 118 (02) : 303 - 312
  • [37] Flixotide™-pressurized metered-dose inhalers loaded with [18F]fluticasone propionate particles for drug deposition studies in humans with PET-formulation and analysis
    Constantinou, M
    Waters, SL
    Steel, CJ
    Poole, KG
    Marino, PS
    Ind, PW
    Rhodes, CG
    Aigbirhio, FI
    Moore, A
    Pike, VW
    Luthra, SK
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2004, 47 (01) : 55 - 70
  • [38] Assessment of the efficacy and safety of fluticasone propionate and salmeterol delivered as a combination dry powder via a capsule-based inhaler and a multi-dose inhaler in patients with asthma
    Chan, Robert
    Sousa, Ana R.
    Mallett, Stephen
    Hynds, Peter
    Homayoun-Valiani, Farshid
    Tabberer, Maggie
    Mehta, Rashmi
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2016, 41 : 19 - 24
  • [39] Comparison of the Pharmacokinetics of Salmeterol and Fluticasone Propionate 50/100 µg Delivered in Combination as a Dry Powder Via a Capsule-Based Inhaler and a Multi-Dose Inhaler
    Rashmi Mehta
    Kylie Riddell
    Ashutosh Gupta
    Margaret D Louey
    Robert H. Chan
    Clinical Drug Investigation, 2015, 35 : 319 - 326
  • [40] A Comparison of Fluticasone Propionate, 100μg Twice Daily, Administered Via a CFC and Non-CFC Propellant, HFA 134a, in Adult Patients with Asthma
    D. W. G. Stone
    M. L. Mairs
    L. Willits
    R. K. Sharma
    Clinical Drug Investigation, 2001, 21 : 695 - 703
12345